Statistics and logistics: Design of Ebola vaccine trials in West Africa.
作者信息
Nason Martha
机构信息
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
出版信息
Clin Trials. 2016 Feb;13(1):87-91. doi: 10.1177/1740774515620612. Epub 2016 Jan 14.
PMID:26768560
Abstract
摘要
相似文献
1
Statistics and logistics: Design of Ebola vaccine trials in West Africa.
Clin Trials. 2016 Feb;13(1):87-91. doi: 10.1177/1740774515620612. Epub 2016 Jan 14.
2
Simulation-guided phase 3 trial design to evaluate vaccine effectiveness to prevent Ebola virus disease infection: Statistical considerations, design rationale, and challenges.
Clin Trials. 2016 Feb;13(1):57-65. doi: 10.1177/1740774515621059. Epub 2016 Jan 14.
3
A US Food and Drug Administration perspective on evaluating medical products for Ebola.
Clin Trials. 2016 Feb;13(1):105-9. doi: 10.1177/1740774515620613. Epub 2016 Jan 14.
4
[Overview of the Ebola vaccines in pre-clinical and clinical development].
Bull Soc Pathol Exot. 2016 Oct;109(4):256-261. doi: 10.1007/s13149-016-0521-2. Epub 2016 Sep 19.
5
Clinical trials of Ebola vaccine must continue despite fall in number of cases.
BMJ. 2015 Feb 17;350:h944. doi: 10.1136/bmj.h944.
6
A viewpoint on European Medicines Agency experience with investigational medicinal products for Ebola.
Clin Trials. 2016 Feb;13(1):101-4. doi: 10.1177/1740774515619860. Epub 2016 Jan 14.
7
As Ebola epidemic begins to slow, trials of drugs and vaccines speed up.
JAMA. 2015 Mar 10;313(10):1000-2. doi: 10.1001/jama.2015.0942.
8
[Ebola vaccine, therapeutics, and diagnostics].
Uirusu. 2016;66(1):63-72. doi: 10.2222/jsv.66.63.
9
Implementation of an Ebola virus disease vaccine clinical trial during the Ebola epidemic in Liberia: Design, procedures, and challenges.
Clin Trials. 2016 Feb;13(1):49-56. doi: 10.1177/1740774515621037. Epub 2016 Jan 14.
10
Ebola R&D woes spur action.
Nature. 2015 May 28;521(7553):405-6. doi: 10.1038/521405a.
引用本文的文献
1
Quantifying Efficiency Gains of Innovative Designs of Two-Arm Vaccine Trials for COVID-19 Using an Epidemic Simulation Model.
Stat Biopharm Res. 2022 Jan 2;14(1):33-41. doi: 10.1080/19466315.2021.1939774. Epub 2021 Jul 30.
2
Response adaptive intervention allocation in stepped-wedge cluster randomized trials.
Stat Med. 2022 Mar 15;41(6):1081-1099. doi: 10.1002/sim.9317. Epub 2022 Jan 21.
3
Challenges of evaluating and modelling vaccination in emerging infectious diseases.
Epidemics. 2021 Dec;37:100506. doi: 10.1016/j.epidem.2021.100506. Epub 2021 Oct 5.
4
An evidence mapping and analysis of registered COVID-19 clinical trials in China.
BMC Med. 2020 Jun 1;18(1):167. doi: 10.1186/s12916-020-01612-y.
5
Design of vaccine efficacy trials during public health emergencies.
Sci Transl Med. 2019 Jul 3;11(499). doi: 10.1126/scitranslmed.aat0360.
6
Choices in vaccine trial design in epidemics of emerging infections.
PLoS Med. 2018 Aug 7;15(8):e1002632. doi: 10.1371/journal.pmed.1002632. eCollection 2018 Aug.
Zotero 插件